COST-EFFECTIVENESS ANALYSIS OF ADDING HPV VACCINATION TO CERVICAL CANCER SCREENING PROGRAM IN HUNGARY

被引：1
|
作者：
Voko, Z. [1 ]
Nagyjanosi, L. [2 ]
Kalo, Z. [1 ]
机构：
[1] Eotvos Lorand Univ, Budapest, Hungary
[2] Syreon Res Inst, Budapest, Hungary
来源：
VALUE IN HEALTH | 2010年 / 13卷 / 07期
关键词：
D O I：
10.1016/S1098-3015(11)71998-2
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A270 / A271
页数：2
相关论文
共 50 条
  • [1] Cost-effectiveness analysis of HPV vaccination alongside cervical cancer screening programme in Slovenia
    Obradovic, Marko
    Mrhar, Ales
    Kos, Mitja
    [J]. EUROPEAN JOURNAL OF PUBLIC HEALTH, 2010, 20 (04): : 415 - 421
  • [2] Cost-effectiveness analysis of adding a quadrivalent HPV vaccine to the cervical cancer screening programme in Switzerland
    Szucs, Thomas D.
    Largeron, Nathalie
    Dedes, Konstantin J.
    Rafia, Rachid
    Benard, Steve
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (05) : 1473 - 1483
  • [3] Modeling Cost-Effectiveness of Cervical Cancer Screening in Hungary
    Voko, Zoltan
    Nagyjanosi, Laszlo
    Margitai, Barnabas
    Koevi, Rita
    Toth, Zoltan
    Laszlo, Daniel
    Kalo, Zoltan
    [J]. VALUE IN HEALTH, 2012, 15 (01) : 39 - 45
  • [4] Cost-effectiveness of adding vaccination with the AS04-adjuvanted human papillomavirus 16/18 vaccine to cervical cancer screening in Hungary
    Zoltán Vokó
    László Nagyjánosi
    Zoltán Kaló
    [J]. BMC Public Health, 12
  • [5] Cost-effectiveness of adding vaccination with the AS04-adjuvanted human papillomavirus 16/18 vaccine to cervical cancer screening in Hungary
    Voko, Zoltan
    Nagyjanosi, Laszlo
    Kalo, Zoltan
    [J]. BMC PUBLIC HEALTH, 2012, 12
  • [6] BEYOND CERVICAL CANCER: THE COST-EFFECTIVENESS OF HPV VACCINATION IN THE NETHERLANDS
    Setiawan, D.
    Cao, Q.
    Westra, T. A.
    Postma, M. J.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A416 - A417
  • [7] Cost-Effectiveness of HPV Vaccination in the Prevention of Cervical Cancer in Malaysia
    Ezat, Wan Puteh Sharifa
    Aljunid, Syed
    [J]. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2010, 11 (01) : 79 - 90
  • [8] A cost-effectiveness analysis of adding a human papillomavirus vaccine to the Australian National Cervical Cancer Screening Program
    Kulasingam, Shalini
    Connelly, Luke
    Conway, Elizabeth
    Flocking, Jane S.
    Myers, Evan
    Regan, David G.
    Roder, David
    Ross, Jayne
    Wain, Gerard
    [J]. SEXUAL HEALTH, 2007, 4 (03) : 165 - 175
  • [9] The impact of alternate HPV vaccination and cervical screening strategies in Japan: a cost-effectiveness analysis
    Palmer, Matthew R.
    Saito, Eiko
    Katanoda, Kota
    Sakamoto, Haruka
    Hocking, Jane S.
    Brotherton, Julia M. L.
    Ong, Jason J.
    [J]. LANCET REGIONAL HEALTH-WESTERN PACIFIC, 2024, 44
  • [10] Cost-effectiveness of primary HPV screening for cervical cancer in Germany - a decision analysis
    Sroczynski, G.
    Schnell-Inderst, P.
    Muehlberger, N.
    Lang, K.
    Aidelsburger, P.
    Wasem, J.
    Mittendorf, T.
    Engel, J.
    Hillemanns, P.
    Petry, K. U.
    Kraemer, A.
    Siebert, U.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 (11) : 1633 - 1646
12345